Trial Outcomes & Findings for Utility of Vancomycin Loading: A Pharmacokinetic Analysis in Critically Ill Patients (NCT NCT01157533)
NCT ID: NCT01157533
Last Updated: 2013-03-18
Results Overview
Peak level (PK blood samples) drawn 4 hours after the completion of loading dose. Sequential trough levels drawn 30 minutes before each standard vancomycin dose for the next 4 doses. PK testing measures the amount of study drug in the body at different time points, with trough testing following 5 doses (1 dose every 8 to 12 hours).
TERMINATED
NA
1 participants
Up to 5 days
2013-03-18
Participant Flow
Recruitment Period: June 21, 2010 to January 4, 2012. All recruitment done at The University of Texas MD Anderson Cancer Center.
Participant milestones
| Measure |
Vancomycin Loading
Loading dose 30 mg/kg via central or peripheral intravenous infusion. Subsequent doses of vancomycin (15 mg/kg) are considered standard of care.
|
|---|---|
|
Overall Study
STARTED
|
1
|
|
Overall Study
COMPLETED
|
1
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Utility of Vancomycin Loading: A Pharmacokinetic Analysis in Critically Ill Patients
Baseline characteristics by cohort
| Measure |
Vancomycin Loading
n=1 Participants
Loading dose 30 mg/kg via central or peripheral intravenous infusion. Subsequent doses of vancomycin (15 mg/kg) are considered standard of care.
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
1 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
1 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
1 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Up to 5 daysPopulation: Unable to complete analysis planned due to low enrollment.
Peak level (PK blood samples) drawn 4 hours after the completion of loading dose. Sequential trough levels drawn 30 minutes before each standard vancomycin dose for the next 4 doses. PK testing measures the amount of study drug in the body at different time points, with trough testing following 5 doses (1 dose every 8 to 12 hours).
Outcome measures
Outcome data not reported
Adverse Events
Vancomycin Loading
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Ara Vaporciyan, MD, BS/ Professor
The University of Texas (UT) MD Anderson Cancer Center
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place